# Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer

> **NCT01565499** · PHASE2 · COMPLETED · sponsor: **Spanish Breast Cancer Research Group** · enrollment: 83 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Nab-paclitaxel

## Key facts

- **NCT ID:** NCT01565499
- **Lead sponsor:** Spanish Breast Cancer Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-17
- **Primary completion:** 2014-06-01
- **Final completion:** 2018-05-27
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2023-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01565499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01565499, "Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01565499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*